Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Summit Therapeutics (SMMT) over the last 10 years, with Q3 2025 value amounting to $22000.0.

  • Summit Therapeutics' Exchange Rate Effect fell 8070.18% to $22000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $13000.0, marking a year-over-year decrease of 9640.88%. This contributed to the annual value of -$18000.0 for FY2024, which is 10214.54% down from last year.
  • Per Summit Therapeutics' latest filing, its Exchange Rate Effect stood at $22000.0 for Q3 2025, which was down 8070.18% from $61000.0 recorded in Q2 2025.
  • In the past 5 years, Summit Therapeutics' Exchange Rate Effect ranged from a high of $1.4 million in Q4 2022 and a low of -$1.8 million during Q3 2022
  • For the 5-year period, Summit Therapeutics' Exchange Rate Effect averaged around $3736.8, with its median value being $22000.0 (2025).
  • Within the past 5 years, the most significant YoY rise in Summit Therapeutics' Exchange Rate Effect was 42816.23% (2022), while the steepest drop was 62173.91% (2022).
  • Quarter analysis of 5 years shows Summit Therapeutics' Exchange Rate Effect stood at -$419000.0 in 2021, then skyrocketed by 428.16% to $1.4 million in 2022, then crashed by 80.22% to $272000.0 in 2023, then tumbled by 139.71% to -$108000.0 in 2024, then surged by 120.37% to $22000.0 in 2025.
  • Its Exchange Rate Effect was $22000.0 in Q3 2025, compared to $61000.0 in Q2 2025 and $38000.0 in Q1 2025.